Clinical Characteristics of Different Human Cytomegalovirus Glycoprotein N Genotypes among Child Patients in China

Abstract

Objective This study aimed to investigate the relationship between clinical characteristics and human cytomegalovirus (HCMV) glycoprotein N (gN) genotypes in children.

Methods HCMV gN gene polymorphisms in 544 patients were analyzed using semi-nested polymerase chain reaction and restriction fragment length polymorphism.

Results The highest proportion was observed for the gN3a genotype (126/544, 23.2%). The proportion of children with mixed infections presenting with the hepatitis phenotype (65/69, 94.2%) was significantly higher than that of each gN genotype, except for gN3b (34/43, 79.1%, all p < 0.0083). Patients infected with 4b genotype (56/56, 100%) had a significantly higher proportion of anemia symptoms than those infected with all other gN genotypes (all p < 0.0083). There were also significant differences in the proportion of patients infected with different gN genotypes who presented with clinical features, such as jaundice, pneumonia, and thrombocytopenic purpura. Patients with the gN2 genotype had significantly higher albumin levels than those with the gN3a genotype (p = 0.042).

Conclusion The clinical phenotypes and laboratory indicators of HCMV infection in children with different gN genotypes are somewhat different, suggesting that precise typing of gN genes has clinical value.

Keywords

human cytomegalovirus - glycoprotein N - genotype - clinical characteristics - children

^* These authors contributed equally to this work and share the first authorship.

Publication History

Received: 01 November 2023

Accepted: 13 May 2024

Article published online:
13 June 2024

• References

• 1 Zuhair M, Smit GSA, Wallis G. et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol 2019; 29 (03) e2034
• 2 Pesch MH, Schleiss MR. Emerging concepts in congenital cytomegalovirus. Pediatrics 2022; 150 (02) e2021055896
• 3 Rasmussen L, Geissler A, Winters M. Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J Infect Dis 2003; 187 (05) 809-819
• 4 Nguyen CC, Siddiquey MNA, Zhang H, Li G, Kamil JP. Human cytomegalovirus tropism modulator UL148 interacts with SEL1L, a cellular factor that governs endoplasmic reticulum-associated degradation of the viral envelope glycoprotein gO. J Virol 2018; 92 (18) e00688-e18
• 5 Weiler N, Paal C, Adams K. et al. Role of envelope glycoprotein complexes in cell-associated spread of human cytomegalovirus. Viruses 2021; 13 (04) 614
• 6 Xia CS, Zhang Z. Analysis of human cytomegalovirus glycoprotein N genotypes in Chinese hematopoietic stem cell transplant recipients. Arch Virol 2011; 156 (01) 17-23
• 7 Chou SW, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991; 163 (06) 1229-1234
• 8 Shepp DH, Match ME, Lipson SM, Pergolizzi RG. A fifth human cytomegalovirus glycoprotein B genotype. Res Virol 1998; 149 (02) 109-114
• 9 Trincado DE, Scott GM, White PA, Hunt C, Rasmussen L, Rawlinson WD. Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol 2000; 61 (04) 481-487
• 10 Jiang XJ, Zhang J, Xiong Y. et al. Human cytomegalovirus glycoprotein polymorphisms and increasing viral load in AIDS patients. PLoS One 2017; 12 (05) e0176160
• 11 Pignatelli S, Dal Monte P, Landini MP. gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes. J Gen Virol 2001; 82 (Pt 11): 2777-2784
• 12 Pignatelli S, Dal Monte P, Rossini G. et al. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 2003; 84 (Pt 3): 647-655
• 13 Bates M, Monze M, Bima H, Kapambwe M, Kasolo FC, Gompels UA. CIGNIS study group. High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa. Virology 2008; 382 (01) 28-36
• 14 Kabanova A, Marcandalli J, Zhou T. et al. Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer. Nat Microbiol 2016; 1 (08) 16082
• 15 Stegmann C, Hochdorfer D, Lieber D. et al. A derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus and inhibits entry into fibroblasts and endothelial cells. PLoS Pathog 2017; 13 (04) e1006273
• 16 Wu Y, Prager A, Boos S. et al. Human cytomegalovirus glycoprotein complex gH/gL/gO uses PDGFR-α as a key for entry. PLoS Pathog 2017; 13 (04) e1006281
• 17 Chou S. Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. J Infect Dis 1992; 166 (03) 604-607
• 18 Paterson DA, Dyer AP, Milne RS, Sevilla-Reyes E, Gompels UA. A role for human cytomegalovirus glycoprotein O (gO) in cell fusion and a new hypervariable locus. Virology 2002; 293 (02) 281-294
• 19 Rasmussen L, Geissler A, Cowan C, Chase A, Winters M. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J Virol 2002; 76 (21) 10841-10848
• 20 Paradowska E, Jabłońska A, Studzińska M. et al. Distribution of cytomegalovirus gN variants and associated clinical sequelae in infants. J Clin Virol 2013; 58 (01) 271-275
• 21 Dong N, Cao L, Su L. et al. Human cytomegalovirus envelope glycoprotein B, H, and N polymorphisms among infants of Shanghai area in China. J Med Virol 2020; 92 (12) 3674-3681
• 22 Mujtaba G, Khurshid A, Sharif S. et al. Distribution of cytomegalovirus genotypes among neonates born to infected mothers in Islamabad, Pakistan. PLoS One 2016; 11 (07) e0156049
• 23 Pati SK, Novak Z, Purser M. et al. Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N. Clin Vaccine Immunol 2012; 19 (06) 909-913
• 24 Li W, Liu L, Tao R, Zheng X, Li H, Shang S. Epidemiological characteristics of human cytomegalovirus infection and glycoprotein H genotype in Chinese children. Pediatr Neonatol 2020; 61 (01) 63-67
• 25 Brañas P, Blázquez-Gamero D, Galindo A. et al. Cytomegalovirus genotype distribution among congenitally and postnatally infected patients: association of particular glycoprotein (g)B and gN types with symptomatic disease. Open Forum Infect Dis 2015; 2 (04) ofv151
• 26 Handous I, Hannachi N, Achour B. et al. Cytomegalovirus glycoprotein polymorphisms and increasing viral load in non-transplant patients with hematological malignancies undergoing chemotherapy: a prospective observational study. Infect Dis Ther 2021; 10 (03) 1549-1566
• 27 Pati SK, Pinninti S, Novak Z. et al; NIDCD CHIMES Study Investigators. Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection. Pediatr Infect Dis J 2013; 32 (10) 1050-1054
• 28 Yang H, Wu K, Zhang H. et al. IgA, albumin, and eosinopenia as early indicators of cytomegalovirus infection in patients with acute ulcerative colitis. BMC Gastroenterol 2020; 20 (01) 294